BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10668701)

  • 1. The association between APOE and dementia does not seem to be mediated by vascular factors.
    Prince M; Lovestone S; Cervilla J; Joels S; Powell J; Russ C; Mann A
    Neurology; 2000 Jan; 54(2):397-402. PubMed ID: 10668701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
    Irie F; Fitzpatrick AL; Lopez OL; Kuller LH; Peila R; Newman AB; Launer LJ
    Arch Neurol; 2008 Jan; 65(1):89-93. PubMed ID: 18195144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
    Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
    Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
    Davidson Y; Gibbons L; Purandare N; Byrne J; Hardicre J; Wren J; Payton A; Pendleton N; Horan M; Burns A; Mann DM
    Dement Geriatr Cogn Disord; 2006; 22(1):15-9. PubMed ID: 16645276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.
    Molero AE; Pino-Ramírez G; Maestre GE
    Neurosci Lett; 2001 Jul; 307(1):5-8. PubMed ID: 11516561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia.
    Hirono N; Yasuda M; Tanimukai S; Kitagaki H; Mori E
    Stroke; 2000 Jun; 31(6):1263-8. PubMed ID: 10835442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
    Kivipelto M; Helkala EL; Laakso MP; Hänninen T; Hallikainen M; Alhainen K; Iivonen S; Mannermaa A; Tuomilehto J; Nissinen A; Soininen H
    Ann Intern Med; 2002 Aug; 137(3):149-55. PubMed ID: 12160362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's disease.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2005; 20(5):292-7. PubMed ID: 16166776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenilin gene predisposes to late-onset degenerative but not vascular dementia: a comparative study of PS1 and ApoE genes in a North Indian Cohort.
    Pandey P; Pradhan S; Mittal B
    Dement Geriatr Cogn Disord; 2007; 24(3):151-61. PubMed ID: 17627113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement.
    Rippon GA; Tang MX; Lee JH; Lantigua R; Medrano M; Mayeux R
    Neurology; 2006 Jan; 66(1):35-40. PubMed ID: 16401842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?
    Guo Z; Fratiglioni L; Viitanen M; Lannfelt L; Basun H; Fastbom J; Winblad B
    Am J Epidemiol; 2001 Feb; 153(3):225-31. PubMed ID: 11157409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.
    Hall K; Murrell J; Ogunniyi A; Deeg M; Baiyewu O; Gao S; Gureje O; Dickens J; Evans R; Smith-Gamble V; Unverzagt FW; Shen J; Hendrie H
    Neurology; 2006 Jan; 66(2):223-7. PubMed ID: 16434658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease.
    Bretsky PM; Buckwalter JG; Seeman TE; Miller CA; Poirier J; Schellenberg GD; Finch CE; Henderson VW
    Alzheimer Dis Assoc Disord; 1999; 13(4):216-21. PubMed ID: 10609670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.